Medical Device: Supply Chain Complexity & Agility
Addressed $11.1 MM+ overage in raw material components and $5.6 MM+ overage in finished goods inventory
Supply chains have proven a compelling scapegoat, but many of the recent challenges reveal underlying dysfunction that preceded the pandemic. For one medical device manufacturer, supply chain (SC) complexity was creating costly overages in materials and finished inventory. Their build-to-order SC process optimized part and component costs, but did so at the expense of lead times, agility to market, inventory levels, risks, procurement serviceability and total SC costs. Here’s how we armed our client with a comprehensive plan to achieve greater supply chain efficacy and competitiveness.